Prenatal Brain Abnormalities in Sodium‐Dependent Multivitamin Transporter Deficiency
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64102 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Eri Ogawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), Japan Society for the Promotion of Science (JSPS) KAKENHI, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
In treatable neurometabolic disorders, early diagnosis and prompt initiation of treatment are key to improved survival and outcomes. Biallelic variants in SLC5A6 cause sodium‐dependent multivitamin transporter deficiency (OMIM # 618973), which is treatable with high‐dose pantothenic acid, biotin, and alpha lipoic acid. So far, the onset has been postnatal in all reported patients. A review of the prenatal imaging showed ventriculomegaly at 32 weeks of gestation. After birth, the infant exhibited developmental regression. At 6 months of age, he developed acute metabolic shock in the setting of a urinary tract infection. Rapid exome analysis identified compound heterozygous pathogenic variants in SLC5A6 and confirmed the diagnosis of sodium‐dependent multivitamin transporter deficiency. After the infant was initiated on treatment with high‐dose biotin and pantothenic acid, we noted dramatic improvements in the hematological, cutaneous, cardiac, and gastrointestinal symptoms. Although the infant showed no further regression, he continued to have significant psychomotor disability. A review of the findings during pregnancy showed that the infant already had enlarged ventricles in late pregnancy, and neuroimaging on day 12 of birth showed signs of energy failure in late pregnancy. Our review of previously reported patients suggested no clear genotype–phenotype correlations, but there was little intrafamilial variability in disease onset. The present observation, for the first time, provides clinical evidence of a fetal onset in sodium‐dependent multivitamin transporter deficiency. The high risk of recurrence and the low intrafamilial variability in disease onset suggest that identification and prenatal treatment in the high‐risk group may be of significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
- Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
- Department of Pediatric Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
ORCID-Profile: Eri Ogawa, Toshiki Takenouchi
Förderung
- Japan Agency for Medical Research and Development (AMED)
- Japan Society for the Promotion of Science (JSPS) KAKENHI
- Japan Society for the Promotion of Science
Zitieren
APA
Ogawa, E., Kosaki, K., & Takenouchi, T. (2025). Prenatal Brain Abnormalities in Sodium‐Dependent Multivitamin Transporter Deficiency. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64102
Vancouver
Ogawa E, Kosaki K, Takenouchi T. Prenatal Brain Abnormalities in Sodium‐Dependent Multivitamin Transporter Deficiency. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64102
BibTeX
@article{Ogawa2025,
author = {Ogawa, Eri and Kosaki, Kenjiro and Takenouchi, Toshiki},
title = {Prenatal Brain Abnormalities in Sodium‐Dependent Multivitamin Transporter Deficiency},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64102}
}
EUVIMED